Corrigendum to “Non-covalent mTOR inhibition suppresses NLRP3-GSDMD inflammasome-mediated pyroptosis” [Biochem. Pharm. 243 (2026) 117459]
Biochemical Pharmacology · 2026-12 · 254 · 118595
DOI: 10.1016/j.bcp.2026.118595 ↗Kurz gefasst
Korrektur in der Zeitschrift Biochemical Pharmacology, 2026-12. Verfasst von Xueqin Jiang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, China.
- Division of Thyroid Surgery, Department of General Surgery and Laboratory of Thyroid and Parathyroid Disease, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chen…
- Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, China. Electronic address: haoyu_ye@scu.edu.cn.
Zitieren
APA
Jiang, X., Zhang, X., Cai, X., Tang, M., Peng, J., Zhang, R., Su, K., Lin, L., Ma, R., Shen, C., Wu, W., & Ye, H. (2026). Corrigendum to “Non-covalent mTOR inhibition suppresses NLRP3-GSDMD inflammasome-mediated pyroptosis” [Biochem. Pharm. 243 (2026) 117459]. Biochemical Pharmacology, 254, 118595. https://doi.org/10.1016/j.bcp.2026.118595
Vancouver
Jiang X, Zhang X, Cai X, Tang M, Peng J, Zhang R, et al. Corrigendum to “Non-covalent mTOR inhibition suppresses NLRP3-GSDMD inflammasome-mediated pyroptosis” [Biochem. Pharm. 243 (2026) 117459]. Biochemical Pharmacology. 2026;254:118595. doi:10.1016/j.bcp.2026.118595
BibTeX
@article{Jiang2026,
author = {Jiang, Xueqin and Zhang, Xinlu and Cai, Xiaoying and Tang, Minghai and Peng, Jing and Zhang, Ruijia and Su, Kaiyue and Lin, Lei and Ma, Rupei and Shen, Caiyun and Wu, Wenshuang and Ye, Haoyu},
title = {Corrigendum to “Non-covalent mTOR inhibition suppresses NLRP3-GSDMD inflammasome-mediated pyroptosis” [Biochem. Pharm. 243 (2026) 117459]},
journal = {Biochemical Pharmacology},
year = {2026},
volume = {254},
pages = {118595},
doi = {10.1016/j.bcp.2026.118595}
}
EUVIMED